GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 28, 2024
Displaying entries 3701 - 3750 of 39437 in total
PDB ID ▼ UniProt ID Title Descriptor
8H14 P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conformation
8H13 P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Conformation
8H12 P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Locked-2 Conformation
8H11 P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Closed Conformation
8H10 P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conformation
8H0Z P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
8H0Y P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Conformation
8H0X P59594 Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-1 Conformation
8H08 P0DTC2 SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H08 8H08 SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H08 P0DTC2 SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H08 8H08 SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H07 P0DTC2 SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H07 8H07 SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H07 P0DTC2 SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H07 8H07 SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C
8H06 Q9BYF1 Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement)
8H06 P0DTC2 Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement)
8H01 P0DTC2 SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
8H01 8H01 SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
8H00 P0DTC2 SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation
8H00 8H00 SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation
8GZ5 P0DTC2 Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-binding domain
8GZ5 8GZ5 Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-binding domain
8GZ3 P13498 Structure of human phagocyte NADPH oxidase in the resting state
8GZ3 P04839 Structure of human phagocyte NADPH oxidase in the resting state
8GZ3 8GZ3 Structure of human phagocyte NADPH oxidase in the resting state
8GZ2 Q9UQD0 Cryo-EM structure of human NaV1.6/beta1/beta2-4,9-anhydro-tetrodotoxin
8GZ2 O60939 Cryo-EM structure of human NaV1.6/beta1/beta2-4,9-anhydro-tetrodotoxin
8GZ2 Q07699 Cryo-EM structure of human NaV1.6/beta1/beta2-4,9-anhydro-tetrodotoxin
8GZ1 Q9UQD0 Cryo-EM structure of human NaV1.6/beta1/beta2,apo state
8GZ1 O60939 Cryo-EM structure of human NaV1.6/beta1/beta2,apo state
8GZ1 Q07699 Cryo-EM structure of human NaV1.6/beta1/beta2,apo state
8GYY G8GLP2 Bifunctional xylosidase/glucosidase LXYL with intermediate substrate xylose, 120 seconds
8GYT Q96QZ0 Cryo-EM structure of human Pannexin-3 R36S/F40R variant in pre-open state.
8GYQ Q96RD6 Cryo-EM structure of human Pannexin-2 in pre-open state.
8GYP Q96QZ0 Cryo-EM structure of human Pannexin-3 in closed state.
8GYO Q96RD7 Inner channel lipids regulated gating mechanism of human pannexins.
8GYE Q07011 Crystal Structure of the 4-1BB in complex with ZG033 Fab
8GYE 8GYE Crystal Structure of the 4-1BB in complex with ZG033 Fab
8GX9 P0DTC2 Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5
8GX9 8GX9 Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5
8GVM P00396 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P68530 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P00415 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P00423 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P00426 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P00428 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P07471 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days
8GVM P00429 The structure of azide-bound cytochrome C oxidase determined using the crystals exposed to 20 mm azide solution for 4 days

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024